Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein

Virology

Volumn 292, Issue 1, 2002, Pages 150-155

  Snitkovsky, Sophie ^a   Young, John A T ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

ASLV; Bridge proteins; GATE; Heregulin; Retrovirus; Targeting

Indexed keywords

CELL SURFACE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN SUBUNIT; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BIRD DISEASE; CANCER CELL; CELL SURFACE; CONTROLLED STUDY; GENE OVEREXPRESSION; LEUKEMIA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RETROVIRUS; RETROVIRUS INFECTION; VIRAL GENE DELIVERY SYSTEM;

AVES; SUBGROUP A; UNIDENTIFIED RETROVIRUS;

EID: 0036058346     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1314     Document Type: Article

References (39)

1. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor
2. Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types
3. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis
4. A neu acquaintance for erbB3 and erbB4: A role for receptor heterodimerization in growth signaling
5. Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3
6. Modification of retroviral tropism by display of IGF-I
7. Targeting retrovirus entry
8. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells
9. Functional and selective targeting of adenovirus to high-affinity Fcgamma receptor I-positive cells by using a bispecific hybrid adapter
10. The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker
11. Heterotransplantation of human breast carcinomas in nude mice. Correlation between successful heterotransplants, poor prognosis and amplification of the HER-2/neu oncogene
12. Antibody-mediated binding of a murine ecotropic Moloney retroviral vector to human cells allows internalization but not the establishment of the proviral state
13. Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin
14. Identification of heregulin, a specific activator of p185erbB2
15. Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies
16. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide
17. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions
18. Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody
19. Retrovirus targeting by tropism restriction to melanoma cells
20. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein
21. Targeting of retroviral vectors through protease-substrate interactions
22. Cell-type specific interaction of Neu differentiation factor (NDF/ heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships
23. Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors
24. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family
25. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene
26. The HER-2/neu oncogene: Prognostic factor, predictive factor and target for therapy
27. A versatile and potentially general approach to the targeting of specific cell types by retroviruses: Application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses
28. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
29. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
30. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin
31. A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor
32. Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein
33. Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein
34. Domain libraries: Synthetic diversity for de novo design of antibody V-regions
35. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms
36. Gene therapy - Promises, problems and prospects
37. Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit
38. Identification of the block in targeted retroviral-mediated gene transfer
39. Residue Trp-48 of TVA is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses